Zika viral dynamics and shedding in rhesus and cynomolgus macaques CE Osuna, SY Lim, C Deleage, BD Griffin, D Stein, LT Schroeder, ... Nature medicine 22 (12), 1448, 2016 | 325 | 2016 |
Evaluation of Euroimmun anti-Zika virus IgM and IgG enzyme-linked immunosorbent assays for Zika virus serologic testing AG L'Huillier, A Hamid-Allie, E Kristjanson, L Papageorgiou, S Hung, ... Journal of clinical microbiology 55 (8), 2462-2471, 2017 | 109 | 2017 |
DNA vaccination protects mice against Zika virus-induced damage to the testes BD Griffin, K Muthumani, BM Warner, A Majer, M Hagan, J Audet, ... Nature communications 8 (1), 15743, 2017 | 102 | 2017 |
Evaluation of 5 commercially available Zika virus immunoassays D Safronetz, A Sloan, DR Stein, E Mendoza, N Barairo, C Ranadheera, ... Emerging infectious diseases 23 (9), 1577, 2017 | 93 | 2017 |
Ebolavirus evolution: past and present MA de La Vega, D Stein, GP Kobinger PLoS pathogens 11 (11), e1005221, 2015 | 76 | 2015 |
Current research for a vaccine against Lassa hemorrhagic fever virus BM Warner, D Safronetz, DR Stein Drug design, development and therapy, 2519-2527, 2018 | 68 | 2018 |
Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination A Ssemaganda, HM Nguyen, F Nuhu, N Jahan, CM Card, S Kiazyk, ... Nature communications 13 (1), 3357, 2022 | 52 | 2022 |
A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in guinea pigs DR Stein, BM Warner, G Soule, K Tierney, KL Frost, S Booth, D Safronetz npj Vaccines 4 (1), 8, 2019 | 36 | 2019 |
High pH reversed‐phase chromatography as a superior fractionation scheme compared to off‐gel isoelectric focusing for complex proteome analysis DR Stein, X Hu, SJ McCorrister, GR Westmacott, FA Plummer, TB Ball, ... Proteomics 13 (20), 2956-2966, 2013 | 36 | 2013 |
Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison F Cholette, C Mesa, A Harris, H Ellis, K Cachero, P Lacap, Y Galipeau, ... PloS one 16 (12), e0261003, 2021 | 32 | 2021 |
Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2 K Dust, A Hedley, K Nichol, D Stein, H Adam, JA Karlowsky, J Bullard, ... Journal of Virological Methods 285, 113970, 2020 | 30 | 2020 |
Nanobodies: a new approach for the diagnosis and treatment of viral infectious diseases P Sroga, D Safronetz, DR Stein Future Virology 15 (3), 195-205, 2020 | 24 | 2020 |
Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in mice DR Stein, JW Golden, BD Griffin, BM Warner, C Ranadheera, L Scharikow, ... Antiviral research 146, 164-173, 2017 | 23 | 2017 |
Vesicular stomatitis virus-based vaccines provide cross-protection against andes and sin nombre viruses BM Warner, DR Stein, RK Jangra, MM Slough, P Sroga, A Sloan, KL Frost, ... Viruses 11 (7), 645, 2019 | 20 | 2019 |
Simulated Sunlight Decreases the Viability of SARS-CoV-2 in Mucus A Sloan, T Cutts, BD Griffin, S Kasloff, Z Schiffman, M Chan, J Audet, ... | 18 | 2020 |
Development and Characterization of a Sin Nombre Virus Transmission Model in Peromyscus maniculatus BM Warner, DR Stein, BD Griffin, K Tierney, A Leung, A Sloan, D Kobasa, ... Viruses 11 (2), 183, 2019 | 18 | 2019 |
Multisystem inflammatory syndrome following SARS-CoV-2 vaccination in two children C Karatzios, R Scuccimarri, G Chédeville, W Basfar, J Bullard, DR Stein Pediatrics 150 (2), e2021055956, 2022 | 17 | 2022 |
COVID-19: A year later: Practical guidance for clinical laboratories for SARS-CoV-2 serology testing C Charlton, J Kanji, V Tran, J Kus, J Gubbay, C Osiowy, J Robinson, ... Canada Communicable Disease Report 47 (4), 171, 2021 | 15 | 2021 |
Mx2 expression is associated with reduced susceptibility to HIV infection in highly exposed HIV seronegative Kenyan sex workers DR Stein, SY Shaw, LR McKinnon, M Abou, SJ McCorrister, ... Aids 29 (1), 35-41, 2015 | 14 | 2015 |
Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories DR Stein, C Osiowy, A Gretchen, L Thorlacius, D Fudge, A Lang, I Sekirov, ... Diagnostic Microbiology and Infectious Disease 101 (3), 115412, 2021 | 11 | 2021 |